Tackling Taboo Health Issues Through R&D in Startups
Many new health startups are looking to tackle problems that are underserved by currently available products and services. With strong incentives to focus on neglected market opportunities, these ventures have the potential to have a profound, positive impact on thorny problems. This is particularly the case with health issues that are considered ‘taboo’: problems that are rarely discussed, either in public or in private, and that stigmatise those that experience them.
This report presents the key activities and findings from our Taboo Health Programme, led by Zinc and funded by a Public Engagement Award from the Wellcome Trust.